EQUITY RESEARCH MEMO

Complete Genomics

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

Complete Genomics, founded in 2005 and headquartered in San Jose, California, is a private company dedicated to transforming genomics to improve lives. The company operates in the genetics and diagnostics sectors, focusing on developing innovative sequencing technologies and diagnostic solutions. While specific financial details and pipeline information are limited, Complete Genomics has established a presence in the competitive genomics market, emphasizing affordability and accessibility. The company's mission to change how genomics is approached aligns with industry trends toward precision medicine and personalized healthcare. Although its current stage and funding status are undisclosed, the company's longevity suggests resilience and potential for future growth.

Upcoming Catalysts (preview)

  • TBDNext-generation sequencing platform launch50% success
  • TBDStrategic partnership or licensing deal60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)